Cortria Overview
- Year Founded
-
2005
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
Cortria General Information
Description
Developer of medicines for the treatment of cardiovascular diseases. The company's product is used for the treatment of dyslipidemia, an atherogenic disorder characterized by abnormal lipid levels in the bloodstream.
Contact Information
Corporate Office
- Old City Hall
- 45 School Street
- Boston, MA 02108
- United States
Corporate Office
- Old City Hall
- 45 School Street
- Boston, MA 02108
- United States
Cortria Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 20-Aug-2010 | Completed | Clinical Trials - General | |||
| 2. Early Stage VC (Series B) | 10-Jul-2009 | Completed | Clinical Trials - General | |||
| 1. Early Stage VC (Series A) | 06-Nov-2008 | $8.8M | $8.8M | Completed | Product Development |
Cortria Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A |
Cortria Patents
Cortria Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2009244395-A1 | 1-methylnicotinamide analogs | Inactive | 06-May-2008 | ||
| CA-2722292-A1 | 1-methylnicotinamide analogs | Inactive | 06-May-2008 | ||
| EP-2285379-A1 | 1-methylnicotinamide analogs | Inactive | 06-May-2008 | ||
| EP-2285379-A4 | 1-methylnicotinamide analogs | Inactive | 06-May-2008 | ||
| WO-2009137527-A1 | 1-methylnicotinamide analogs | Inactive | 06-May-2008 | A61K31/44 |
Cortria Former Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| CV Ventures | Venture Capital | Minority | ||
| Domain Associates | Venture Capital | Minority | ||
| MVM Partners | Growth/Expansion | Minority |
Cortria FAQs
-
When was Cortria founded?
Cortria was founded in 2005.
-
Where is Cortria headquartered?
Cortria is headquartered in Boston, MA.
-
What industry is Cortria in?
Cortria’s primary industry is Pharmaceuticals.
-
Is Cortria a private or public company?
Cortria is a Private company.
-
What is Cortria’s current revenue?
The current revenue for Cortria is .
-
How much funding has Cortria raised over time?
Cortria has raised $10.6M.
-
Who are Cortria’s investors?
CV Ventures, Domain Associates, and MVM Partners have invested in Cortria.
-
When was Cortria acquired?
Cortria was acquired on 20-Aug-2010.
-
Who acquired Cortria?
Cortria was acquired by Pharmena.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process